Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1979 1
1980 1
1981 2
1982 1
1983 2
1984 2
1985 5
1986 7
1987 4
1988 15
1989 13
1990 12
1991 16
1992 15
1993 10
1994 15
1995 16
1996 22
1997 28
1998 25
1999 44
2000 43
2001 55
2002 62
2003 62
2004 97
2005 108
2006 125
2007 125
2008 144
2009 171
2010 180
2011 200
2012 212
2013 254
2014 300
2015 311
2016 300
2017 363
2018 411
2019 465
2020 581
2021 625
2022 538
Text availability
Article attribute
Article type
Publication date

Search Results

5,407 results
Results by year
Filters applied: . Clear all
Page 1
Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma.
Dong L, Lu D, Chen R, Lin Y, Zhu H, Zhang Z, Cai S, Cui P, Song G, Rao D, Yi X, Wu Y, Song N, Liu F, Zou Y, Zhang S, Zhang X, Wang X, Qiu S, Zhou J, Wang S, Zhang X, Shi Y, Figeys D, Ding L, Wang P, Zhang B, Rodriguez H, Gao Q, Gao D, Zhou H, Fan J. Dong L, et al. Among authors: cai s. Cancer Cell. 2022 Jan 10;40(1):70-87.e15. doi: 10.1016/j.ccell.2021.12.006. Epub 2021 Dec 30. Cancer Cell. 2022. PMID: 34971568
Metastasis.
Lyden D, Ghajar CM, Correia AL, Aguirre-Ghiso JA, Cai S, Rescigno M, Zhang P, Hu G, Fendt SM, Boire A, Weichselbaum RR, Katipally RR. Lyden D, et al. Among authors: cai s. Cancer Cell. 2022 Aug 8;40(8):787-791. doi: 10.1016/j.ccell.2022.07.010. Cancer Cell. 2022. PMID: 35944497
Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection.
Bao H, Wang Z, Ma X, Guo W, Zhang X, Tang W, Chen X, Wang X, Chen Y, Mo S, Liang N, Ma Q, Wu S, Xu X, Chang S, Wei Y, Zhang X, Bao H, Liu R, Yang S, Jiang Y, Wu X, Li Y, Zhang L, Tan F, Xue Q, Liu F, Cai S, Gao S, Peng J, Zhou J, Shao Y. Bao H, et al. Among authors: cai s. Mol Cancer. 2022 Jun 11;21(1):129. doi: 10.1186/s12943-022-01594-w. Mol Cancer. 2022. PMID: 35690859 Free PMC article. Clinical Trial.
Retraction Note: The PI3K/mTOR Dual Inhibitor BEZ235 Nanoparticles Improve Radiosensitization of Hepatoma Cells Through Apoptosis and Regulation DNA Repair Pathway.
Tang X, Li A, Xie C, Zhang Y, Liu X, Xie Y, Wu B, Zhou S, Huang X, Ma Y, Cao W, Xu R, Shen J, Huo Z, Cai S, Liang Y, Ma D. Tang X, et al. Among authors: cai s. Nanoscale Res Lett. 2021 Dec 16;16(1):179. doi: 10.1186/s11671-021-03638-4. Nanoscale Res Lett. 2021. PMID: 34914025 Free PMC article. No abstract available.
5,407 results